Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Fusion Pharmaceuticals Inc. (FUSN) had Receiveable Turnover of 295.43 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$2.07M |
|
$-94.90M |
|
-- |
|
$2.07M |
|
$101.30M |
|
$-99.23M |
|
$5.12M |
|
$-94.11M |
|
$-94.11M |
|
$-94.90M |
|
$-94.90M |
|
$-94.90M |
|
$-94.90M |
|
$-99.23M |
|
$-97.89M |
|
65.61M |
|
65.61M |
|
$-1.45 |
|
$-1.45 |
|
| Balance Sheet Financials | |
$243.40M |
|
$5.30M |
|
$42.44M |
|
$285.84M |
|
$16.22M |
|
$34.77M |
|
$47.14M |
|
$63.36M |
|
$222.48M |
|
$222.48M |
|
$222.48M |
|
79.70M |
|
| Cash Flow Statement Financials | |
$-81.80M |
|
$-42.76M |
|
$142.01M |
|
$45.33M |
|
$62.77M |
|
$17.44M |
|
$12.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.01 |
|
-- |
|
-- |
|
0.14 |
|
0.16 |
|
100.00% |
|
-4798.45% |
|
-4798.45% |
|
-4733.41% |
|
-4550.77% |
|
-4588.83% |
|
$-85.69M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
|
Receiveable Turnover |
295.43 |
1.24 |
|
-42.65% |
|
-42.65% |
|
-33.20% |
|
-36.89% |
|
$2.79 |
|
$-1.31 |
|
$-1.25 |
|